Evidence-based asthma care
Map of Medicine analyses the evidence on asthma care and suggests interventions to achieve productivity improvements while maintaining quality and safety.
For further information go to www.mapofmedicine.com/solution/productivityconsiderations
The Map of Medicine systematically monitors medical literature for the latest productivity interventions and will update this document as new evidence emerges. Last update: 28-Jan-2011 Version: 1.0
The productivity considerations presented in this document are relevant to the UK.
They were identified by systematically searching for and appraising productivity evidence from multiple sources, including NICE guidance, health economic databases and Zynx Health (a sister company of Map of Medicine).
A productivity message explicitly states interventions that can reduce the cost of care, while maintaining or improving patient outcomes.
Actions that are believed to lead to improved productivity, but lack unequivocal clinical or economic evidence, are not included.
Some productivity considerations are informed by more recent evidence than that included in relevant national guidelines. The document has been peer reviewed.
1 National Institute for Health and Clinical Excellence (NICE). Inhaled corticosteroids for the treatment of chronic asthma in children under the age of 12 years. Technology Appraisal Guidance 131. London, 2007
2 National Institute for Health and Clinical Excellence (NICE). Inhaled corticosteroids for the treatment of chronic asthma in adults and in children aged 12 years and over. Technology Appraisal Guidance 138. London, 2008
This document is not to be substituted for a healthcare professional's advice
© 2011 Map of Medicine Ltd Asthma 1/1